Jamm Therapeutics

JAMM Therapeutics is a drug discovery company developing small molecule modulators of the BRISC deubiquitinating enzyme complex, for the treatment of systemic lupus erythematosus (SLE). SLE is the most common form of Lupus, an autoimmune disease that causes widespread inflammation and tissue damage in the affected organs.

Related Profiles

 Dietary Assessment ltd

Food science company

 Cell Lane Ltd

Medical device company

 Xeros

Water conservation company